Sudeep Pharma 2026 Report: Pharma Excipients and Battery Growth
Sudeep Pharma, listed on NSE in November 2025, reports 49% revenue growth to 172 crore in Q3 FY26 and enters battery materials via iron phosphate for EVs.
Analysis of stocks listed on NSE and BSE — fundamentals, quarterly results, valuations, and corporate actions
Sudeep Pharma, listed on NSE in November 2025, reports 49% revenue growth to 172 crore in Q3 FY26 and enters battery materials via iron phosphate for EVs.
Tata Technologies proposes Common Facility Centres in Jhansi and Chitrakoot under UP Defence Industrial Corridor with ₹35,526 crore investment proposals.
Shipping Corporation of India (SCI) trades at 290-295 rupees with a P/E of 12 and 2.3% dividend yield, backed by fleet expansion plans for 26 new vessels…
RBI cancels Paytm Payments Bank licence effective April 24, 2026, ending a saga of KYC violations, compliance failures and restrictions since 2018.
Bhagyanagar India Limited (BHAGYANGR) shares have hit fresh all-time highs after the NCLT Hyderabad Bench admitted the long-awaited Composite Scheme of…